207 related articles for article (PubMed ID: 32847822)
1. Tailored support for national NCD policy and programme implementation: an over-looked priority.
Jackson-Morris A; Nugent R
BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32847822
[TBL] [Abstract][Full Text] [Related]
2. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
NCD Countdown 2030 collaborators
Lancet; 2022 Mar; 399(10331):1266-1278. PubMed ID: 35339227
[TBL] [Abstract][Full Text] [Related]
3. The reported impact of non-communicable disease investment cases in 13 countries.
Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; Keskinkiliç B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
[TBL] [Abstract][Full Text] [Related]
4. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
[TBL] [Abstract][Full Text] [Related]
5. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
[TBL] [Abstract][Full Text] [Related]
6. Implementation factors of non-communicable disease policies and programmes for children and youth in low-income and middle-income countries: a systematic review.
Nguyen GT; Gauvreau C; Mansuri N; Wight L; Wong B; Neposlan J; Petricca K; Denburg A
BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38830723
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options.
Rani M; Nusrat S; Hawken LH
BMC Public Health; 2012 Oct; 12():877. PubMed ID: 23067232
[TBL] [Abstract][Full Text] [Related]
8. 'Implementability' matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries.
Jackson-Morris AM; Mutungi G; Maree E; Waqanivalu T; Marten R; Nugent R
BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35418410
[TBL] [Abstract][Full Text] [Related]
9. The dynamic of non-communicable disease control policy in Indonesia.
Christiani Y; Dugdale P; Tavener M; Byles JE
Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
[TBL] [Abstract][Full Text] [Related]
10. A narrative review of gaps in the provision of integrated care for noncommunicable diseases in India.
Pati MK; Swaroop N; Kar A; Aggarwal P; Jayanna K; Van Damme W
Public Health Rev; 2020; 41():8. PubMed ID: 32435518
[TBL] [Abstract][Full Text] [Related]
11. Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target.
Cao B; Bray F; Ilbawi A; Soerjomataram I
Lancet Glob Health; 2018 Dec; 6(12):e1288-e1296. PubMed ID: 30420032
[TBL] [Abstract][Full Text] [Related]
12. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
Allen LN; Wigley S; Holmer H; Barlow P
Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
[TBL] [Abstract][Full Text] [Related]
13. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
[TBL] [Abstract][Full Text] [Related]
14. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.
Allen LN; Nicholson BD; Yeung BYT; Goiana-da-Silva F
Lancet Glob Health; 2020 Jan; 8(1):e50-e58. PubMed ID: 31813787
[TBL] [Abstract][Full Text] [Related]
15. The International Society for Behavioral Medicine (ISBM) and the Society of Behavioral Medicine (SBM) advocate for the inclusion of behavioral scientists in the implementation of the Global Action Plan for the prevention of non-communicable diseases (NCDs) in low- and middle-income countries.
Odukoya O; Fox RS; Hayman LL; Penedo FJ
Transl Behav Med; 2021 Jun; 11(6):1286-1288. PubMed ID: 33410489
[TBL] [Abstract][Full Text] [Related]
16. Financing national non-communicable disease responses.
Allen LN
Glob Health Action; 2017; 10(1):1326687. PubMed ID: 28604238
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the use of mathematical modelling to support decision-making on integration of non-communicable diseases into HIV care.
Kibachio J; Mwenda V; Ombiro O; Kamano JH; Perez-Guzman PN; Mutai KK; Guessous I; Beran D; Kasaie P; Weir B; Beecroft B; Kilonzo N; Kupfer L; Smit M
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25505. PubMed ID: 32562338
[TBL] [Abstract][Full Text] [Related]
18. Tracing Africa's progress towards implementing the Non-Communicable Diseases Global action plan 2013-2020: a synthesis of WHO country profile reports.
Nyaaba GN; Stronks K; de-Graft Aikins A; Kengne AP; Agyemang C
BMC Public Health; 2017 Apr; 17(1):297. PubMed ID: 28381252
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
